Stock listing

NASDAQ:RNA Atrium Therapeutics, Inc. Stock

Home listing (NASDAQ) of Atrium Therapeutics, Inc.

Follow Atrium Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:RNA

$8.32 USD +0.27 (+3.4%)

Close on Oct 27, 2026

Past 6 months -43.6% · daily closes, Feb 27, 2026 – Oct 27, 2026, adjusted for splits
Day range
$8.05 – $8.39 USDOct 27, 2026
Volume
198,570 sharesOct 27, 2026
Market cap
$142.3M USDAt the close on Oct 27, 2026 · price × 17.11M shares outstanding
Atrium Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:RNA · Home$8.32 USD+0.27 (+3.4%)198,570$8.05$8.39$8.05$8.05Close on Oct 27, 2026

Daily closes

Last 3 months, Jul 27, 2026 – Oct 27, 2026 · NASDAQ:RNA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$8.32+0.27+3.4%$8.05$8.39$8.05198,570
$8.05-0.15-1.8%$8.20$8.23$7.98187,366
$8.20+0.04+0.5%$8.06$8.21$7.78192,660
$8.16+0.16+2.0%$8.01$8.185$7.945173,482
$8.00+0.02+0.3%$7.97$8.32$7.96193,208
$7.98+0.37+4.9%$7.75$8.27$7.71289,488
$7.61-0.06-0.8%$7.68$7.87$7.49243,913
$7.67-0.15-1.9%$7.79$8.06$7.67190,978
$7.82+0.14+1.8%$7.75$7.87$7.64131,236
$7.68-0.07-0.9%$7.75$7.935$7.54269,494
$7.75-0.46-5.6%$8.22$8.22$7.75237,187
$8.21-0.19-2.3%$8.40$8.482$8.2187,396
$8.40+0.14+1.7%$8.29$8.50$8.135208,348
$8.26+0.33+4.2%$8.15$8.325$7.965649,309
$7.93-0.06-0.8%$7.95$8.13$7.9391,818
$7.99+0.02+0.3%$8.00$8.07$7.78411,686
$7.97+0.13+1.7%$7.83$8.105$7.63268,285
$7.84-0.30-3.7%$8.22$8.421$7.68533,805
$8.14-0.14-1.7%$8.30$8.44$7.96395,723
$8.28-0.14-1.7%$8.38$8.46$8.22197,306
$8.420.000.0%$8.42$8.50$8.21158,804
$8.42+0.13+1.6%$8.21$8.515$8.05504,915
$8.29+0.10+1.2%$8.20$8.365$8.10221,427
$8.19-0.14-1.7%$8.30$8.49$8.16355,242
$8.33-0.89-9.7%$9.22$9.31$8.29434,524
$9.22+0.03+0.3%$9.24$9.485$9.17241,277
$9.19+0.24+2.7%$8.97$9.34$8.943481,266
$8.95-0.61-6.4%$9.57$9.665$8.661,036,990
$9.56+0.06+0.6%$9.65$9.695$9.435569,619
$9.50-0.59-5.8%$10.11$10.11$9.50356,436
$10.09-0.12-1.2%$10.21$10.21$9.62274,580
$10.21-0.15-1.4%$10.37$10.71$10.15255,714
$10.36+0.01+0.1%$10.37$10.41$10.00247,499
$10.35-0.16-1.5%$10.44$10.74$10.28421,628
$10.51-0.84-7.4%$11.20$11.20$10.34690,444
$11.35-2.84-20.0%$14.08$14.19$10.751,722,578
$14.19-0.41-2.8%$14.51$14.65$14.01167,785
$14.60+0.54+3.8%$14.19$14.68$13.99164,905
$14.06+0.29+2.1%$13.77$14.10$13.76111,641
$13.77+0.45+3.4%$13.24$13.92$13.20178,705
$13.32-0.32-2.3%$13.53$13.55$13.1097,048
$13.64-0.34-2.4%$13.87$13.95$13.51108,637
$13.98+0.13+0.9%$13.78$14.09$13.59120,562
$13.85-0.15-1.1%$13.93$14.07$13.66179,349
$14.00+0.38+2.8%$13.72$14.05$13.41166,578
$13.62+0.42+3.2%$13.27$13.64$13.04140,555
$13.20-0.28-2.1%$13.53$13.59$12.96180,677
$13.48-0.23-1.7%$13.75$13.88$13.20218,806
$13.71+0.87+6.8%$13.00$13.72$12.85360,317
$12.84-0.12-0.9%$12.91$12.96$12.72107,917
$12.96+0.12+0.9%$12.78$13.35$12.78212,552
$12.84+0.51+4.1%$12.21$12.97$12.08176,079
$12.33+0.16+1.3%$12.21$12.46$12.03127,137
$12.17-0.10-0.8%$12.27$12.35$12.0684,174
$12.27+0.03+0.2%$12.25$12.44$12.2084,252
$12.24-0.10-0.8%$12.25$12.44$12.20108,983
$12.34+0.23+1.9%$12.15$12.49$12.15103,286
$12.11+0.37+3.2%$11.96$12.31$11.88193,102
$11.74+0.20+1.7%$11.53$11.99$11.46171,863
$11.54+0.21+1.9%$11.40$11.74$11.35137,005
$11.33-0.02-0.2%$11.45$11.53$11.3091,505
$11.35-0.11-1.0%$11.44$11.54$11.20116,293
$11.46+0.28+2.5%$11.19$11.55$11.1991,837
$11.18-0.31-2.7%$11.46$11.46$11.13119,407
$11.49-0.08-0.7%$11.59$11.63$11.3691,974
$11.57+0.08+0.7%$11.61$11.80$11.4682,816
Ticker
NASDAQ:RNA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Atrium Therapeutics, Inc. news

Decks

Atrium Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
17 in the last 12 months · 138 in all · newest Oct 27, 2026 · oldest 2020
Decks
2 decks · latest October 2026

Where Atrium Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:RNA · Home listing · This pageNASDAQUnited StatesUSD
BOATS:RNABOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Atrium Therapeutics, Inc.